{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:21:30Z","timestamp":1790623290626,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cct.2020.106014","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T14:36:43Z","timestamp":1587998203000},"page":"106014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations"],"prefix":"10.1016","volume":"93","author":[{"given":"Theresa","family":"Winhusen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wexelblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Merhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly F.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail G.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Guille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.cct.2020.106014_bb0005","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jama.2012.4526","article-title":"Epidemic of prescription opiate abuse and neonatal abstinence","volume":"307","author":"Hayes","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2020.106014_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.cct.2020.106014_bb0015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4070","article-title":"U.S.E. committee on substance, prevention, a public health response to opioid use in pregnancy","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.cct.2020.106014_bb0025","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.cct.2020.106014_bb0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J. Perinatol."},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: fetal and neonatal consequences","volume":"1","author":"Kandall","year":"1977","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.cct.2020.106014_bb0040","series-title":"Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and their Infants","author":"Abuse","year":"2018"},{"issue":"1","key":"10.1016\/j.cct.2020.106014_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.cct.2020.106014_bb0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40263-015-0273-8","article-title":"Pharmacological management of opioid use disorder in pregnant women","volume":"29","author":"Wilder","year":"2015","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.cct.2020.106014_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.cct.2020.106014_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsat.2013.02.008","article-title":"Retention in methadone and buprenorphine treatment among African Americans","volume":"45","author":"Gryczynski","year":"2013","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2020.106014_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0080","doi-asserted-by":"crossref","first-page":"459 e1","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2016.8897","article-title":"Improving outcomes for persons with opioid use disorders: buprenorphine implants to improve adherence and access to care","volume":"316","author":"Compton","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.cct.2020.106014_bb0090","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.clinthera.2015.05.505","article-title":"Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy","volume":"37","author":"Iglay","year":"2015","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ADM.0000000000000099","article-title":"The effect of methadone dose regimen on neonatal abstinence syndrome","volume":"9","author":"McCarthy","year":"2015","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.cct.2020.106014_bb0100","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s40064-016-2576-8","article-title":"Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?","volume":"5","author":"Shah","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.cct.2020.106014_bb0105","series-title":"FDA Advisory Committee Meeting Briefing Document: CAM2038 (buprenorphine) subcutaneous injection","author":"Braeburn Pharmaceuticals Inc.","year":"2017"},{"issue":"24","key":"10.1016\/j.cct.2020.106014_bb0110","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2020.106014_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1360-0443.2012.04036.x","article-title":"Maternal opioid treatment: human experimental research (MOTHER)-approach, issues and lessons learned","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cct.2020.106014_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cct.2020.106014_bb0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3945\/ajcn.112.037184","article-title":"Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: a randomized, double-blind, placebo-controlled trial","volume":"96","author":"Cheatham","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cct.2020.106014_bb0130","series-title":"Choline, Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","first-page":"390","author":"Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes","year":"1998"},{"key":"10.1016\/j.cct.2020.106014_bb0135","author":"American Medical Association"},{"key":"10.1016\/j.cct.2020.106014_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cattod.2017.04.008","article-title":"Diglyceride-rich oils from glycerolysis of edible vegetable oils","volume":"302","author":"Ferretti","year":"2018","journal-title":"Catal. Today"},{"issue":"9","key":"10.1016\/j.cct.2020.106014_bb0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/jp.2012.57","article-title":"Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn","volume":"32","author":"Burd","year":"2012","journal-title":"J. Perinatol."},{"issue":"7","key":"10.1016\/j.cct.2020.106014_bb0150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/add.13341","article-title":"Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries","volume":"111","author":"Kalinowski","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2020.106014_bb0155","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ajad.12687","article-title":"Treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine + naloxone exposure","volume":"27","author":"Nguyen","year":"2018","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine plus naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","volume":"22","author":"Debelak","year":"2013","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0170","first-page":"E194","article-title":"Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence retrospective cohort study of 30 patients","volume":"62","author":"Dooley","year":"2016","journal-title":"Can. Fam. Physician"},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.cct.2020.106014_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011774","article-title":"Observational study of the safety of buprenorphine plus naloxone in pregnancy in a rural and remote population","volume":"6","author":"Jumah","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0185","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6488.1000269","article-title":"Buprenorphine with, or without, naloxone for pregnant women?\u2013review of current evidence and practice in Massachusetts","volume":"5","author":"Krsak","year":"2017","journal-title":"J. Alcohol. Drug Depend."},{"key":"10.1016\/j.cct.2020.106014_bb0190","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jsat.2010.01.011","article-title":"The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment","volume":"38","author":"Tai","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"issue":"6","key":"10.1016\/j.cct.2020.106014_bb0195","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamainternmed.2018.1052","article-title":"Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial","volume":"178","author":"Lofwall","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.cct.2020.106014_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jrh.12260","article-title":"Medication-assisted opioid treatment prescribers in federally qualified health Centers: capacity lags in rural areas","volume":"34","author":"Jones","year":"2018","journal-title":"J. Rural Health"},{"issue":"15","key":"10.1016\/j.cct.2020.106014_bb0205","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1517\/14656566.2014.955469","article-title":"Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies","volume":"15","author":"Li","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0210","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1542\/peds.2015-1141","article-title":"Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study","volume":"136","author":"Hall","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.cct.2020.106014_bb0215","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3835","article-title":"Improving Care for Neonatal Abstinence Syndrome","volume":"137","author":"Patrick","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr."},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.acap.2016.10.003","article-title":"Wide variation found in care of opioid-exposed newborns","volume":"17","author":"Bogen","year":"2017","journal-title":"Acad. Pediatr."},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.cct.2020.106014_bb0235","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2020.106014_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.02.030","article-title":"Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study","volume":"150","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.cct.2020.106014_bb0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2020.106014_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2014.10.002","article-title":"Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients","volume":"145","author":"McHugh","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.cct.2020.106014_bb0255","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2105\/AJPH.84.9.1486","article-title":"The adequacy of prenatal care utilization index: its US distribution and association with low birthweight","volume":"84","author":"Kotelchuck","year":"1994","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.cct.2020.106014_bb0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2020.106014_bb0265","series-title":"Ages & Stages Questionnaires\u00ae, Third Edition (ASQ- 3TM). A Parent-Completed Child-Monitoring System","author":"Squires","year":"2009"},{"issue":"3","key":"10.1016\/j.cct.2020.106014_bb0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jpepsy\/22.3.313","article-title":"Revision of a parent-completed development screening tool: ages and stages questionnaires","volume":"22","author":"Squires","year":"1997","journal-title":"J. Pediatr. Psychol."},{"issue":"1","key":"10.1016\/j.cct.2020.106014_bb0275","first-page":"5","article-title":"Ages and stages questionnaire: a global screening scale","volume":"74","author":"Singh","year":"2017","journal-title":"Boletin Medico Del Hospital Infantil de Mexico"},{"issue":"6","key":"10.1016\/j.cct.2020.106014_bb0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.cct.2020.106014_bb0285","series-title":"Cost Effectiveness in Health and Medicine","author":"Neumann","year":"2017"},{"issue":"1\u20133","key":"10.1016\/j.cct.2020.106014_bb0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2007.06.004","article-title":"Initial reliability and validity studies of the revised treatment services review (TSR-6)","volume":"92","author":"Cacciola","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.cct.2020.106014_bb0295","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.cct.2020.106014_bb0300","author":"HealthMeasures"},{"issue":"6","key":"10.1016\/j.cct.2020.106014_bb0305","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0272989X18776637","article-title":"Estimation of a preference-based summary score for the patient-reported outcomes measurement information system: the PROMIS((R))-preference (PROPr) scoring system","volume":"38","author":"Dewitt","year":"2018","journal-title":"Med. Decision Making"},{"issue":"12","key":"10.1016\/j.cct.2020.106014_bb0310","first-page":"3377","article-title":"Selection of key health domains from PROMIS((R)) for a generic preference-based scoring system","volume":"26","author":"Hanmer","year":"2017","journal-title":"Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehab."},{"key":"10.1016\/j.cct.2020.106014_bb0315","series-title":"Non-Inferiority Clinical Trials to Establish Effectiveness: Guidance for Industry","author":"FDA Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research","year":"2016"},{"key":"10.1016\/j.cct.2020.106014_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cct.2018.04.001","article-title":"The OPTIMA study, buprenorphine\/naloxone and methadone models of care for the treatment of prescription opioid use disorder: study design and rationale","volume":"69","author":"Socias","year":"2018","journal-title":"Contemp. Clin. Trials"},{"issue":"2","key":"10.1016\/j.cct.2020.106014_bb0325","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2020.106014_bb0330","series-title":"Points to Consider on Switching Between Superiority and Non-inferiority, European Agency for the Evaluation of Medicinal Products, London","author":"Committee for Proprietary Medicinal Products","year":"2000"},{"key":"10.1016\/j.cct.2020.106014_bb0335","series-title":"Economic Evaluation in Clinical Trials","author":"Glick","year":"2014"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:48:35Z","timestamp":1761554915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714420300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":67,"alternative-id":["S1551714420300926"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2020.106014","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2020.106014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106014"}}